AbbVie (Germany) Top Insiders
| 4AB Stock | EUR 173.96 1.94 1.10% |
AbbVie employs about 50 K people. The company is managed by 10 executives with a total tenure of roughly 41 years, averaging almost 4.0 years of service per executive, having 5000.0 employees per reported executive. Examination of AbbVie's management performance can provide insight into the company performance.
| Richard Gonzalez Chairman Chairman of the Board, CEO |
| Timothy Richmond President Senior Vice President - Human Resources |
AbbVie |
AbbVie Management Team Effectiveness
The company has return on total asset (ROA) of 0.0991 % which means that it generated a profit of $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7239 %, meaning that it generated $0.7239 on every $100 dollars invested by stockholders. AbbVie's management efficiency ratios could be used to measure how well AbbVie manages its routine affairs as well as how well it operates its assets and liabilities.AbbVie Workforce Comparison
AbbVie Inc is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is presently estimated at about 84,027. AbbVie totals roughly 50,000 in number of employees claiming about 60% of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39. AbbVie Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AbbVie Inc Price Series Summation is a cross summation of AbbVie price series and its benchmark/peer.
AbbVie Notable Stakeholders
An AbbVie stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AbbVie often face trade-offs trying to please all of them. AbbVie's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AbbVie's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Richard Gonzalez | Chairman of the Board, CEO | Profile | |
| Timothy Richmond | Senior Vice President - Human Resources | Profile | |
| Laura Schumacher | Executive Vice President - Business Development, External Affairs, General Counsel | Profile | |
| Robert Michael | Vice President Controller | Profile | |
| Azita SalekiGerhardt | Senior Vice President - Operations | Profile | |
| Jeffrey Stewart | Senior Vice President U.S. Commercial Operations | Profile | |
| Perry Siatis | Gen VP | Profile | |
| Thomas Hudson | VP Officer | Profile | |
| Elizabeth Shea | VP Relations | Profile | |
| Scott Reents | VP CFO | Profile |
About AbbVie Management Performance
The success or failure of an entity such as AbbVie Inc often depends on how effective the management is. AbbVie management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AbbVie management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AbbVie management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 30000 people.
AbbVie Workforce Analysis
Traditionally, organizations such as AbbVie use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AbbVie within its industry.AbbVie Manpower Efficiency
Return on AbbVie Manpower
| Revenue Per Employee | 1.2M | |
| Revenue Per Executive | 5.8B | |
| Net Income Per Employee | 236.7K | |
| Net Income Per Executive | 1.2B |
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |